FSAGX | RYMPX | FSAGX / RYMPX | |
Total Expense Ratio | 0.68 | 1.55 | 44% |
Annual Report Gross Expense Ratio | 0.68 | 1.58 | 43% |
Fund Existence | 40 years | 22 years | - |
Gain YTD | 59.967 | 50.798 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.24B | 115M | 1,951% |
Annual Yield % from dividends | 2.29 | 0.00 | - |
Returns for 1 year | 72.23 | 53.37 | 135% |
Returns for 3 years | 75.72 | 60.22 | 126% |
Returns for 5 years | 60.17 | 52.48 | 115% |
Returns for 10 years | 166.47 | 137.17 | 121% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MSFD | 11.85 | 0.10 | +0.85% |
Direxion Daily MSFT Bear 1X ETF | |||
UCON | 24.73 | -0.06 | -0.24% |
First Trust Smith Unconstrained Pl BdETF | |||
BMAR | 47.71 | -0.38 | -0.78% |
Innovator U.S. Equity Buffer ETF™ - Mar | |||
PRAY | 29.80 | -0.32 | -1.07% |
FIS Christian Stock ETF | |||
PPH | 90.78 | -1.00 | -1.09% |
VanEck Pharmaceutical ETF |